Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.
about
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerHow should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalEfficacy and safety of antiintegrin antibody for inflammatory bowel disease: a systematic review and meta-analysisIBS-like symptoms in patients with ulcerative colitisCombination therapy for inflammatory bowel diseaseCancer and immunomodulators in inflammatory bowel diseases.Combination therapy for the treatment of Crohn's disease.Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel DiseaseLow-event-rate meta-analyses of clinical trials: implementing good practices.Anal Canal Adenocarcinoma in a Patient with Longstanding Crohn's Disease Arising From Rectal Mucosa that Migrated From a Previously Treated Rectovaginal FistulaAnti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesSecond Korean guidelines for the management of ulcerative colitis.Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.Biologic agents for IBD: practical insights.Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.Practical Approaches to "Top-Down" Therapies for Crohn's Disease.Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan.Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis.Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.Cost-utility Analysis: Thiopurines Plus Endoscopy-guided Biological Step-up Therapy is the Optimal Management of Postoperative Crohn's Disease.Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease.Incidence, management, and course of cancer in patients with inflammatory bowel disease.Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease - authors' reply.Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα).
P2860
Q26750190-C34A91B1-03AA-4052-824B-A7ACD91750FCQ26777409-8C5E3E27-C0F4-4F92-BC5F-7BB677F87CB3Q26801119-8110AD5E-0A11-463E-B78C-E41D22D6E98EQ28084236-B1188E28-C368-4C81-8379-77D8A0424C6FQ28088663-3DD9E0C9-A5E2-4A20-B2BD-63E01904A189Q33646452-A9D3E5FD-542F-495D-825A-3ACBE9222133Q35534959-C567CE4B-E749-47FA-94CA-F331D14E2C14Q35714202-BF07968A-D031-43A2-A143-98C169B72FE6Q35758262-E8C9A58F-CEA7-4B1F-97E8-5E40EC0329D5Q35842876-A80AE101-EEB8-4E19-9E69-D4534CA2E6A7Q36161965-334DBA86-C233-430A-905C-8CA93DDEB58FQ36963353-EA390583-94C7-4FF8-B2E7-150B5D660E08Q37073840-A77F0D48-42D7-4A56-B4A2-E432606CB529Q37354812-266C6CA9-298C-405E-9396-8C84CDFD286FQ37662503-288A588F-6F12-4EAE-8FD3-8F2A367DAE3FQ38186069-EEB4E060-EE88-424F-ABE1-DE4238F7FF10Q38253832-AF1DC687-B45A-448B-84A0-F70A0B254A22Q38365426-D88C2BFD-B3E4-49AC-9DFA-E6E50747EA1CQ38436580-F04F4F75-9DAA-4089-8C95-0DB47969C787Q38568898-1EBB1AB1-1ACE-4D63-9EB7-E056EA6DBF76Q38707449-7E2CCC95-0B13-48A6-96E6-77B7568E5792Q38707864-E0D01BDC-5CE4-48E7-BF2C-E77143C19046Q38835478-2275F937-8648-4612-836C-21113F884D4BQ38947390-630F2EE7-F0D0-43AB-BD0D-5F643EF59901Q39454180-58A3E76A-7606-41A1-8843-D18B56E3C125Q40066358-651A662C-3533-4808-A0DF-63D794D21282Q40431363-B8430F3C-7682-46AD-9703-ECC6DBFAFA1AQ42269880-8DA6FB48-A22B-454D-9EB5-F23FA0B1A310Q47427964-918263BB-0D9F-4F7F-BD59-E59137A20A0BQ48089393-0CD02DD7-D2CB-4D34-8CC8-DE76B3DFA63FQ48530814-EA9078BA-2896-4590-819C-DEB174CDE7B2Q49315243-446FE638-4CC0-4537-A654-3B10D0374083Q50451653-50305EF2-E6D9-4666-9FEC-539FB413F2D3Q52816502-F65E2450-7213-4387-83EF-4C669752BD73Q55506747-F621476F-22CA-41E9-BB11-ED6123C0439C
P2860
Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review with meta-an ...... in inflammatory bowel disease.
@en
Systematic review with meta-an ...... in inflammatory bowel disease.
@en-gb
type
label
Systematic review with meta-an ...... in inflammatory bowel disease.
@en
Systematic review with meta-an ...... in inflammatory bowel disease.
@en-gb
prefLabel
Systematic review with meta-an ...... in inflammatory bowel disease.
@en
Systematic review with meta-an ...... in inflammatory bowel disease.
@en-gb
P2860
P921
P356
P1476
Systematic review with meta-an ...... in inflammatory bowel disease
@en
P2093
L Peyrin-Biroulet
P2860
P304
P356
10.1111/APT.12624
P407
P577
2014-01-20T00:00:00Z